A creator of game therapies for cognitive impairments is becoming a publicly-traded company through a special purpose acquisition company or SPAC. . . . → Read More: Digital Mental Therapy Company to Go Public in Merger
|
|||||
       
  |
Global drug maker Novo Nordisk is acquiring biotechnology company Dicerna Pharmaceuticals Inc. in an all-cash deal valued at $3.3 billion. . . . → Read More: Novo Nordisk Buys RNA Biotech in $3.3B Deal  Comments are closed  Finance  biomedical, biotechnology, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals 
A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger. . . . → Read More: Synthetic Antibody Company Goes Public in $230M Merger Comments are closed Finance biomedical, biotechnology, clinical trials, entrepreneurs, equity, Europe, investment, IPO, merger, pharmaceuticals 
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition. . . . → Read More: RNA Manufacturer Goes Public in $282M Merger Comments are closed Finance agriculture, biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, equity, investment, IPO, life sciences, manufacturing, merger, physical sciences 
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address. . . . → Read More: Protein Chemistry Biotech Acquired in $2B Deal One comment - (Comments are closed) Finance biomedical, biotechnology, chemistry, entrepreneurs, Europe, investment, life sciences, merger, pharmaceuticals, physical sciences, preclinical
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator. . . . → Read More: Sanofi Acquires mRNA Developer in $3.2B Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals 
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals, university, venture capital 
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition. . . . → Read More: Synthetic Bio Company Goes Public in $2.5B Merger Comments are closed Finance biotechnology, economics, engineering, entrepreneurs, equity, genomics, investment, IPO, life sciences, merger, pharmaceuticals
A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery company based on machine learning algorithms. . . . → Read More: AI Drug Discovery Company Acquired in $270M Deal Comments are closed Finance biomedical, biotechnology, cancer, chemistry, engineering, equity, genomics, investment, life sciences, mathematics, merger, physical sciences
GenMark Diagnostics, a developer of diagnostics systems using genomic analysis, was acquired by drug maker Roche in a deal valued at $1.8 billion. . . . → Read More: Molecular Diagnostics Company Acquired in $1.8B Deal Comments are closed Finance biomedical, biotechnology, engineering, equity, investment, life sciences, medical device, merger, physical sciences, university |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
